← Open Payments lookup

RICARDO CUADRA: Open Payments

NPI 1144251372 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$712 in 34 payments from 16 companies in 2025. Trend: 2023 $736 · 2024 $1,184 · 2025 $712

Food & beverage: $613Education: $99
CompanyPaymentsAmount
Novo Nordisk Inc11$150
Astellas Pharma US Inc3$134
Lilly USA, LLC4$91
PFIZER INC.2$55
Boehringer Ingelheim Pharmaceuticals, Inc.2$40
AstraZeneca Pharmaceuticals LP2$38
Insulet Corporation1$25
Otsuka America Pharmaceutical, Inc.1$24
Xeris Pharmaceuticals, Inc.1$24
Dexcom, Inc.1$23

Products named: Ozempic, JARDIANCE, PREVNAR 20, FARXIGA, Veozah, Omnipod, REXULTI, GVOKE HYPOPEN.

Industry payments across TX — which companies pay providers there.